Financial Planning & Information Services, Inc. Amgen Inc Transaction History

Financial Planning & Information Services, Inc.

$725 Million
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $47,295 - $52,631	-205 Reduced 19.52%	845 $206,000
Q1 2022 Apr 19, 2022	SELL	$219.27 - $242.57 $3,289 - $3,638	-15 Reduced 1.41%	1,050 $254,000
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $3,184 - $3,730	15 Added 1.43%	1,065 $226,000
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $10,511 - $11,661	-45 Reduced 4.11%	1,050 $256,000
Q1 2021 Apr 20, 2021	BUY	$221.91 - $258.6 $9,985 - $11,637	45 Added 4.29%	1,095 $272,000
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $2,596 - $3,092	-12 Reduced 1.13%	1,050 $241,000
Q3 2020 May 24, 2021	BUY	$234.65 - $260.95 $249,198 - $277,128	1,062 New	1,062 $270,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Planning & Information Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Planning & Information Services, Inc. with notifications on news.

Account